DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on ...
Budget Gaps Leave ICS/OT at Risk: Despite growing recognition of OT cybersecurity as a priority, only 27 percent of ...
Reported positive initial data from INSPIRE DUCHENNE trial of next-generation Duchenne gene therapy candidate, SGT-003; In mid-2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback